11:37 AM EST - Cipher Pharmaceuticals Inc. : posted a fourth-quarter loss of $500,000 or $0.02 per share, compared to a loss of $1.6 million or $0.07 per share in the same period last year. Cipher recorded licensing revenue of $400,000 for the recent quarter, compared to $200,000 last year. Cipher Pharmaceuticals Inc.
shares T.DND are trading even at $0.82.